Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Updates in the 2024 Korean Thyroid Association Clinical Practice Guidelines for Differentiated Thyroid Cancer: from Diagnosis to Initial Treatment

Lee EK

The 2024 Korean Thyroid Association (KTA) Clinical Practice Guidelines for Differentiated Thyroid Cancer (DTC) introduce updated recommendations based on recent advancements and clinical evidence. These guidelines encompass a broad spectrum...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How to Minimize the Complications of Thyroid Surgery

Lee KD, Kim YJ

The main goal of thyroid cancer treatment is to completely remove the lesion and minimize recurrence. However, given the very favorable prognosis and the quality of life following the extended...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medullary Thyroid Carcinoma with Normal Calcitonin Level

Chang MC, Lee W

Calcitonin is an important tumor marker for medullary thyroid carcinoma. Serum calcitonin is increased in most cases of medullary thyroid carcinoma. However, medullary thyroid carcinoma with normal calcitonin level has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosing Dysphagia Due to Thyroid Nodules by Thyroid Ultrasound, a Case Series

Idrees Z, Morkos M

Background and Objectives: Thyroid nodules can cause dysphagia by direct esophageal compression. Diagnosis of esophageal compression during thyroid ultrasound (US) has not been described. Materials and Methods: We present a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Methimazole-Induced Insulin Autoimmune Syndrome in a Korean Patient with Graves’ Disease Treated with Propylthiouracil: a Case Report and Literature Review

Kim SH, Baek Co, Song SK, Kim JH

Insulin autoimmune syndrome (IAS) is rare. Herein, we report a case of methimazole-induced IAS successfully treated with propylthiouracil (PTU) and review related literature on Korean cases. A 48-year-old woman visited...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Monocarboxylate Transporter 4 Expression in Thyroid Cancer

Kim CA, Yoo J, Lee WK, Song DE, Kim WG, Jeon MJ

Background and Objectives: Monocarboxylate transporter 4 (MCT4) transmembrane proteins are encoded by SLC16A3 and control lactate metabolism to promote tumor growth. Materials and Methods: Gene expression of SLC16A3 encoding MCT4...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
BRAF/ MEK Inhibitors in Downstaging BRAFV600E Mutated Papillary Thyroid Cancer to Allow Resection: Case Report and Literature Review

Dodbiba L, Zhang H, Luthra M, Meyers B

Well-differentiated thyroid cancer is managed with surgical resection, and adjuvant radioactive iodine (RAI) treatment reserved for moderate to high-risk patients. However, some patients with locally advanced disease are not candidates...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Extrathyroidal Extension in Papillary Thyroid Cancer Could be Predicted Through Preoperative Sonography

Yang GE, Cho SW, Ryu YJ, Lee KY, Kim HS, Ohk TG, Choi H

Background and Objectives: Surgical decision-making for papillary thyroid cancer (PTC) relies on accurate preoperative staging, where ultrasonography plays a crucial role in predicting outcomes. We aimed to analyze the predictive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changing Trends of Thyroid Cancer Clinical Characteristics and Treatment Pattern in South Korea: Insights from an Institutional Database and the Korean Cancer Center Registry Database

Kang YJ, Choi N, Seok J, Kim SW, Kim TH, Chung JH, Son YI, Chung MK

Background and Objectives: To analyze the clinical trends and treatment patterns of thyroid cancer in the recent decade in South Korea. Materials and Methods: Two distinctive datasets, a single institutional...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Are TERT Promoter Mutations a Poor Prognostic Factor in Anaplastic Thyroid Carcinoma?

Ryu HJ, Oh YL, Heo J, Park H, Kim TH, Kim SW, Chung JH

Background and Objectives: Telomerase reverse transcriptase (TERT) promoter mutations are a poor prognostic factor in differentiated thyroid carcinoma (DTC). However, their prognostic value in anaplastic thyroid carcinoma (ATC) is unclear....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr